MedTrace Logo

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

NCT07195305 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2026-04-20

No results posted yet for this study

Summary

The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years

Conditions

  • Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)

Interventions

PROCEDURE

Radiofrequency endometrial ablation

Radiofrequency endometrial ablation

PROCEDURE

Uterine artery embolization

Uterine artery embolization

PROCEDURE

Hysterectomy

Hysterectomy

Sponsors & Collaborators

  • French Ministry of Social Affairs and Health

    collaborator UNKNOWN

  • University Hospital, Bordeaux

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-17
Primary Completion
2029-05-31
Completion
2029-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195305 on ClinicalTrials.gov